Minerva Neurosciences Inc reports results for the quarter ended in March - Earnings Summary

Minerva Neurosciences

15/05/2023 14:32

* Minerva Neurosciences Inc  NERV.OQ  reported a quarterly
adjusted loss of $1.31​​ per share for the quarter ended in
March. The lone analyst forecast for the quarter was for a loss
of $1.63 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Minerva Neurosciences Inc's reported EPS for the quarter
was a
loss of $1.31​.
    * The mean earnings estimate of analysts had fallen by
about 24.9%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Minerva Neurosciences Inc shares had risen by 354.4% this
quarter and gained 357.2% so far this year.
    * The company reported a quarterly loss of $6.97 million.
    * Wall Street's median 12-month price target for Minerva
Neurosciences Inc is $8.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
15 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -1.63          -1.31          Beat
 Dec. 31 2022      -0.92          -1.26          Missed
 Sep. 30 2022      -1.32          -1.29          Beat
 Jun. 30 2022      -1.65          -1.63          Beat